Mohamed Alsharedi, MD

Associate Professor

Departments

Clinical Interests

Hospital Privileges

Education & Training

  • Medical School: Al-Fateh University (Tripoli, Libya)
  • Residency: Marshall University Joan C. Edwards School of Medicine (Huntington, W.Va.)
  • Fellowship: Marshall University Joan C. Edwards School of Medicine (Huntington, W.Va.)

Honors & Memberships

  • Member, American College of Physicians
  • Member, American Society of Clinical Oncology
  • Member, American Society of Hematology

Certification

  • Certified: American Board of Internal Medicine, subspecialty certification in Medical Oncology
  • Bone Marrow Transplant Training: Ohio State University, Columbus, Ohio

Additional Languages

  • Arabic

Edwards Comprehensive Cancer Center - Internal Medicine

Cabell Huntington Hospital
1400 Hal Greer Blvd.
Huntington, WV 25701
Phone: 304-399-6500

Map & Directions


Crank, Madison N. 6746693; Iqbal, Arslan: Abedelmasseh, Michael: Alsharedi, Mohamed: Griswold, Doreen: Browne, Alysia; and Sanabria, Juan R.. 2020. Complete Response to Stage IV Colorectal Adenocarcinoma with Disease-free Survival at 24 Months: Case Report abd Overview of the Literature Vol 6: Iss. 2, Article 8

Khan NAJ, Alsharedi M. 2020. Bullous Skin Rash: A Rare Case of Palbociclib-Induced Dermatological Toxicity. Cureus. 2020 9 12;12(9):e10229.
View on PubMed

Bukamur H, Katz H, Alsharedi M, Alkrekshi A, Shweihat YR, Munn NJ. 2020. Immune Checkpoint Inhibitor-Related Pulmonary Toxicity: Focus on Nivolumab. South Med J. 2020 11 4;113(11):600-605.
View on PubMed

Khan NAJ, Pacioles T, Alsharedi M. 2020. Atypical Takotsubo Cardiomyopathy Secondary to Combination of Chemo-Immunotherapy in a Patient With Non-Small Cell Lung Cancer. Cureus. 2020 8 4;12(7):e9429.
View on PubMed

Haydock MM, Elhamdani S, Alsharedi M. 2019. Long-term direct oral anticoagulation in primary osteonecrosis with elevated plasminogen activation inhibitor. SAGE Open Med Case Rep. 2019 2 21;7:2050313X19827747.
View on PubMed

Katz H, Biglow L, Alsharedi M. 2019. Immune Checkpoint Inhibitors in Locally Advanced, Unresectable, and Metastatic Upper Gastrointestinal Malignancies. J Gastrointest Cancer. 2019 4 28.
View on PubMed

Katz H, Sagun S, Griswold D, Alsharedi M. 2018. Solitary Lytic Bone Metastasis: A Rare Presentation of Small Lymphocytic Leukemia. Case Rep Hematol. 2018 12 5;2018:6154709.
View on PubMed

Dotson J, Elhamdani A, Petryna E, Jamil MO, Alsharedi M. 2018. Neutropenic enterocolitis in patients with FLT3 mutated acute myeloid leukemia undergoing induction chemotherapy with midostaurin. Int. J. Hematol. 2018 12 4;109(3):351-355.
View on PubMed

Alsharedi M, Srivastava R, Elmsherghi N. 2018. Durvalumab for the treatment of urothelial carcinoma. Drugs Today. 2018 3 9;53(12):647-652.
View on PubMed

Alsharedi M, Katz H. 2018. Check point inhibitors a new era in renal cell carcinoma treatment. Med. Oncol. 2018 5 8;35(6):85.
View on PubMed

Alsharedi M, Bukamur H, Elhamdani A. 2018. Osimertinib for the treatment of patients with EGFR mutation-positive non-small cell lung cancer. Drugs Today. 2018 7 13;54(6):369-379.
View on PubMed

Alsharedi M, Elmsherghi N, Haydock MM, Bukamur H. 2017. Chemotherapy-related acute respiratory distress syndrome in germ cell tumors: a literature review. Med. Oncol. 2017 3 18;34(4):56.
View on PubMed

Katz H, Wassie E, Alsharedi M. 2017. Checkpoint inhibitors: the new treatment paradigm for urothelial bladder cancer. Med. Oncol. 2017 9 3;34(10):170.
View on PubMed

Raufi A, Alsharedi M, Khelfa Y, Tirona M. 2017. Bilateral Triple-Negative Invasive Breast Cancer with a BRCA2 Mutation, and Glioblastoma: A Case Report and Literature Review. J Breast Cancer. 2017 4 7;20(1):108-111.
View on PubMed

Katz H, Alsharedi M. 2017. Immunotherapy in triple-negative breast cancer. Med. Oncol. 2017 12 20;35(1):13.
View on PubMed

Alsharedi M, Gress T, Dotson J, Elmsherghi N, Tirona MT. 2016. Comparison of toxicity profile and tolerability between two standard of care paclitaxel-based adjuvant chemotherapy regimens in breast cancer. Med. Oncol. 2016 Mar;33(3):27.
View on PubMed

Raufi A, Alsharedi M, Khelfa Y, Griswold DC, Lebowicz Y.. 2016. Leukemia cutis in a patient with chronic lymphocytic leukemia presenting as bilateral helical nodules. SAGE Open Med Case Rep. SAGE Open Med Case Rep. 2016 Dec 1;4:2050313X16683624. doi: 10.1177/2050313X16683624
View on PubMed

Alsharedi M, Zgheib NB, Khelfa Y, Raufi A, Elmsherghi N, Lebowicz Y. 2016. Primary Retroperitoneal Melanoma Presented in a Rare Extracutaneous Site for Malignant Melanoma. Rare Tumors. Rare Tumors. 2016 Oct 5;8(3):6308.
View on PubMed

Talag MM, Alsharedi M, Bou Zgheib N, Lebowicz Y.. 2016. Immunotherapy in a rare case of primary pelvic retroperitoneal melanoma. BMJ Case Rep. BMJ Case Rep. 2016 Sep 13;2016. pii: bcr2016216450. doi: 10.1136/bcr-2016-216450.
View on PubMed

Alsharedi M, Gress T, Dotson J, Elmsherghi N, Tirona MT. 2016. Comparison of toxicity profile and tolerability between two standard of care paclitaxel-based adjuvant chemotherapy regimens in breast cancer. Med Oncol. 2016 Mar;33(3):27. doi: 10.1007/s12032-016-0740-1.
View on PubMed

Ali Raufi, Mohamed Alsharedi, Yousef Khelfa, Doreen C Griswold, and Yehuda Lebowicz. 2016. Leukemia cutis in a patient with chronic lymphocytic leukemia presenting as bilateral helical nodules. SAGE Open Med Case Rep. SAGE Open Med Case Rep. 2016; 4: 2050313X16683624. Published online 2016 Dec 1. doi: 10.1177/2050313X16683624
View on PubMed

Khelfa Y, Alsharedi M, Mehmi I, Raufi A, Arrington A, Lebowicz Y, Pacioles T. 2015. Metastatic Sarcomatoid Carcinoma of the Small Intestine: a Case Report of Rare Tumor with Literature Review. J Gastrointest Cancer. 2015 Nov 6.
View on PubMed

Sehgal R, Alsharedi M, Larck C, Edwards P, Gress T. 2014. Pancreatic cancer survival in elderly patients treated with chemotherapy. Pancreas. 2014 Mar;43(2):306-10.
View on PubMed

Crank, Madison N. 6746693; Iqbal, Arslan: Abedelmasseh, Michael: Alsharedi, Mohamed: Griswold, Doreen: Browne, Alysia; and Sanabria, Juan R.. . Complete Response to Stage IV Colorectal Adenocarcinoma with Disease-free Survival at 24 Months: Case Report abd Overview of the Literature Vol 6: Iss. 2, Article 8